• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION OPTICROSS HD; CATHETER, ULTRASOUND, INTRAVASCULAR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION OPTICROSS HD; CATHETER, ULTRASOUND, INTRAVASCULAR Back to Search Results
Model Number 8668
Device Problem Material Separation (1562)
Patient Problem Foreign Body In Patient (2687)
Event Date 02/07/2024
Event Type  Injury  
Event Description
It was reported that a catheter issue occurred.The 100% stenosed target lesion was located in the moderately tortuous and moderately calcified left anterior descending artery.The opticross hd imaging catheter was advanced for ultrasound examination of the target lesion.During the procedure, at the time of device delivery, a 3-point radiopaque marker was visible on angiography.After completing the imaging, it was confirmed that a radiopaque object remained in the vessel after removal of the device, which appeared to be a foreign object upon examination with optical coherence tomography (oct).The procedure was completed using a different device.No patient complications were reported.
 
Manufacturer Narrative
B1 adverse event/product problem, b2 outcomes attrib to adv event, and h1 type of reportable event: corrected the device was returned for analysis.Visual and microscope inspections revealed the imaging window was observed detached.Based on the evidence, the as reported code of device material separation can be confirmed.
 
Event Description
It was reported that a catheter issue occurred.The 100% stenosed target lesion was located in the moderately tortuous and moderately calcified left anterior descending artery.The opticross hd imaging catheter was advanced for ultrasound examination of the target lesion.During the procedure, at the time of device delivery, a 3-point radiopaque marker was visible on angiography.After completing the imaging, it was confirmed that a radiopaque object remained in the vessel after removal of the device, which appeared to be a foreign object upon examination with optical coherence tomography (oct).The procedure was completed using a different device.No patient complications were reported.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
OPTICROSS HD
Type of Device
CATHETER, ULTRASOUND, INTRAVASCULAR
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
300 boston scientific way
marlborough MA 01752
Manufacturer (Section G)
BOSTON SCIENTIFIC CORPORATION
2546 calle primera
alajuela
CS  
Manufacturer Contact
rachel shields
4100 hamline ave n
arden hills, MN 55112
6512422111
MDR Report Key18817761
MDR Text Key336794180
Report Number2124215-2024-11695
Device Sequence Number1
Product Code OBJ
Combination Product (y/n)N
Reporter Country CodeJA
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,Company Representative,Distributor
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 04/19/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received03/01/2024
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model Number8668
Device Catalogue Number8668
Device Lot Number0032686895
Was Device Available for Evaluation? Device Returned to Manufacturer
Is the Reporter a Health Professional? Yes
Date Manufacturer Received04/09/2024
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured10/23/2023
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other;
-
-